FDA Adverse Event Injury Summary report: N

UNKNOWN DEPUY ASR FEMORAL HEAD

MDR report key: 3951481 · Received July 22, 2014

Report

Report Number
1818910-2014-24010
Event Type
Injury
Date Received
July 22, 2014
Report Date
July 11, 2014
Manufacturer
DEPUY INTL., LTD. - 8010379
Product Code
KXA
Removal / Correction Number
Z-1749/1816-2011
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

NO 510(K) NUMBER PROVIDED BECAUSE THIS IMPLANT IS SOLD INTERNATIONALLY WITH DIFFERENT INDICATIONS FOR USE; IT IS CURRENTLY SOLD IN THE US UNDER A DIFFERENT PART NUMBER. THE CORRECTION/REMOVAL REPORTING NUMBER LISTED APPLIES TO THE CORRESPONDING PRODUCT CODE SOLD DOMESTICALLY. THE ASR PLATFORM WAS VOLUNTARILY RECALLED FROM THE MARKET IN AUGUST 2010, AND THE ASR PRODUCT CODES ARE NOW CONSIDERED INACTIVE. FURTHER INVESTIGATION OF THIS INDIVIDUAL INCIDENT WILL NOT BE UNDERTAKEN, AS THERE IS AN ONGOING INVESTIGATION REGARDING THE ROOT CAUSE(S) AND/OR CORRECTIVE ACTIONS. REF. (B)(4). DEPUY CONSIDERS THE INVESTIGATION CLOSED AT THIS TIME. SHOULD THE PRODUCT AND/OR ADDITIONAL INFORMATION BE RECEIVED, THE INVESTIGATION WILL BE RE-OPENED. IF INFORMATION IS OBTAINED THAT WAS NOT AVAILABLE FOR THE INITIAL MEDWATCH, A FOLLOW-UP MEDWATCH WILL BE FILED AS APPROPRIATE.

Description of Event or Problem · 1

LITIGATION ALLEGES PAIN AND THAT IN OR AROUND (B)(6) 2012, THE PATIENT BEGAN EXPERIENCING SERIOUS COGNITIVE ISSUES, INCLUDING CONCENTRATION, DIFFICULTIES CONSISTING OF FORGETFULNESS AND DISORGANIZATION. THE PATIENT UNDERWENT VARIOUS PSYCHOLOGICAL AND MEDICAL TESTING. IN (B)(6) OF 2013, A BLOOD TEST RESULTS REVEALED THAT PATIENT HAD HIGH LEVELS OF CHROMIUM COBALT IN HIS BLOOD. THIS HIGH AMOUNT OF CHROMIUM COBALT WAS FROM THE IMPLANTED HIP. PATIENT HAD A REVISION SURGERY AT (B)(6) HOSPITAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
428485 UNKNOWN DEPUY ASR FEMORAL HEAD HIP FEMORAL HEAD KXA DEPUY INTL., LTD. - 8010379 UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention